Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
- 2014 -
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2014 - 36 products
L
IP
Abraxane 100 mg
Durchstechflasche(n)
296.98
332.10
10 %
Pulver zur Herstellung einer Infusionsdispersion: Paclitaxelum 100 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
IP
CI
Tecfidera 120 mg
14 Capsule(s)
258.90
287.50
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Biogen Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Tecfidera 240 mg
56 Capsule(s)
1035.63
1100.85
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Biogen Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Tecfidera 240 mg
168
3106.90
3269.75
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Biogen Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Ondansetron ODT Labatec 4 mg
10 Tablet(s)
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
Ondansetron ODT Labatec 8 mg
6 Tablet(s)
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
Xofigo 1100 kBq/ml Ra-223-
Dichlorid
Durchstechflasche(n)
4843.09
5276.80
10 %
Injection solution: Radii(223-Ra) Dichloridum zum Kalibrierungszeitpunkt 6600
Bayer (Schweiz) AG
A / SL
FB
G
L
IP
CI
Zyclara
28 Sachet(s)
104.50
130.05
10 %
Cream: Imiquimodum 37.5 mg/g
Viatris Pharma GmbH
A / SL
FB
G
L
IP
CI
Cholib 145 mg/20 mg
30 Tablet(s)
15.88
33.70
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Cholib 145 mg/20 mg
90 Tablet(s)
47.64
68.25
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Cholib 145 mg/40 mg
30 Tablet(s)
15.88
33.70
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Cholib 145 mg/40 mg
90 Tablet(s)
47.64
68.25
10 %
Coated tablets: 2 Active Agents
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
PP
Forxiga 5 mg
28 Tablet(s)
39.61
59.50
10 %
Coated tablets: Dapagliflozinum 5 mg
AstraZeneca AG
B / SL
FB
G
L
IP
CI
PP
Forxiga 5 mg
98 Tablet(s)
138.64
167.20
10 %
Coated tablets: Dapagliflozinum 5 mg
AstraZeneca AG
B / SL
FB
G
L
IP
CI
PP
Forxiga 10 mg
28 Tablet(s)
39.61
59.50
10 %
Coated tablets: Dapagliflozinum 10 mg
AstraZeneca AG
B / SL
FB
G
L
IP
CI
PP
Forxiga 10 mg
98 Tablet(s)
138.64
167.20
10 %
Coated tablets: Dapagliflozinum 10 mg
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Hemangiol 3.75 mg/ml
Flasche(n)
178.18
210.20
10 %
Solution: Propranololum 3.75 mg/ml
Pierre Fabre Pharma AG
B / SL
FB
G
IP
Levofloxacin Labatec i.v. 500
mg/100 ml
100 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 500mg / 100ml
Labatec Pharma SA
A
FB
G
IP
Levofloxacin Labatec i.v. 500
mg/100 ml
100 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 500mg / 100ml
Labatec Pharma SA
A
FB
G
IP
Levofloxacin Labatec i.v. 500
mg/100 ml
5 x 100 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 500mg / 100ml
Labatec Pharma SA
A
FB
G
IP
PP
Mozobil 20mg/mL
Durchstechflasche(n)
PR
PR
k.A.
Injection solution: Plerixaforum 20 mg/ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
CI
Ondansetron ODT Labatec 4 mg
6 Tablet(s)
PR
PR
k.A.
Melting tablets: Ondansetronum 4 mg
Labatec Pharma SA
B
FB
G
IP
CI
Ondansetron ODT Labatec 8 mg
10 Tablet(s)
PR
PR
k.A.
Melting tablets: Ondansetronum 8 mg
Labatec Pharma SA
B
FB
G
IP
CI
Azalia 0.075 mg
28 Tablet(s)
PR
PR
k.A.
Coated tablets: Desogestrelum
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Azalia 0.075 mg
3 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: Desogestrelum
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Azalia 0.075 mg
6 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: Desogestrelum
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Azalia 0.075 mg
13 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: Desogestrelum
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Gyselle petite 28
28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Gyselle petite 28
3 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 20
21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 20
3 x 21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 20
6 x 21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
3 x 21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
6 x 21 Tablet(s)
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
Aspirin S
20 Tablet(s)
PR
PR
k.A.
überzogene Tabletten: Acidum Acetylsalicylicum 500 mg
Bayer (Schweiz) AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home